Walsh, Zachary H.
Shah, Parin
Kothapalli, Neeharika
Shah, Shivem B. http://orcid.org/0000-0001-9439-6509
Nikolenyi, Gergo http://orcid.org/0000-0003-0581-7864
Brodtman, D. Zack http://orcid.org/0009-0009-6562-0626
Leuzzi, Giuseppe http://orcid.org/0000-0002-2211-790X
Rogava, Meri
Mu, Michael
Ho, Patricia http://orcid.org/0000-0002-4622-8188
Abuzaid, Sinan http://orcid.org/0009-0000-1629-7556
Vasan, Neil http://orcid.org/0000-0003-1779-484X
AlQuraishi, Mohammed http://orcid.org/0000-0001-6817-1322
Milner, Joshua D. http://orcid.org/0000-0002-3913-3869
Ciccia, Alberto http://orcid.org/0000-0003-4789-6564
Melms, Johannes C. http://orcid.org/0000-0002-5410-6586
Izar, Benjamin http://orcid.org/0000-0003-2379-6702
Article History
Received: 1 December 2023
Accepted: 10 April 2024
First Online: 23 May 2024
Competing interests
: B.I. is a consultant for or received honoraria from Volastra Therapeutics, Johnson & Johnson (Janssen), Novartis, Eisai, AstraZeneca and Merck and has received research funding to Columbia University from Agenus, Alkermes, Arcus Biosciences, Checkmate Pharmaceuticals, Compugen, Immunocore, Regeneron and Synthekine. Z.H.W. and B.I. filed a patent application based on this work. The other authors do not have competing interests.